After developing CRISPR test, UConn researchers validate clinical feasibility for COVID-19 testing

(University of Connecticut) In March, researchers in the Department of Biomedical Engineering-- a shared department in the schools of Dental Medicine, Medicine, and Engineering--began to develop a new, low-cost, CRISPR-based diagnostic platform to detect infectious diseases, including HIV virus, the novel coronavirus (SARS-CoV-2). Today, the method is one step closer to being a cutting-edge diagnostics technology for rapid detection of infectious diseases.
Source: EurekAlert! - Biology - Category: Biology Source Type: news